Imatinib use in the management of a patient with Doege–Potter syndrome

Imatinib use in the management of a patient with Doege–Potter syndrome

Doege–Potter syndrome (DPS) is a paraneoplastic syndrome characterized by nonislet cell tumor hypoglycemia due to a solitary fibrous tumor, which produces insulin-like growth factor II. In this report, we present the case of a 67-year-old male with recurrent and refractory hypoglycemia due to DPS su...

Full description

Bibliographic Details
Main Authors: Jose Paz-Ibarra, Jose Lu-Antara, Brenda-Erendida Uscamayta, Jhancy Martinez-Auris, Miriam Valencia-Rivera, Sofía Sáenz-Bustamante, Marialejandra Delgado-Rojas, Julia Salcedo-Vasquez, Marcio Concepción-Zavaleta
Format: Article
Language:English
Published: Bioscientifica 2023-04-01
Series:Endocrinology, Diabetes & Metabolism Case Reports
Online Access:https://edm.bioscientifica.com/view/journals/edm/2023/2/EDM22-0360.xml

Similar Items

Similar Items